A new-fangled norm is likely to be observed by the healthcare vertical going forward. In other words, the novel healthcare vertical normal for supply chains, tech projects, governing critical supplies, regulations, and resilience would be new frameworks built by inter-governmental and governmental agencies for data sharing and response to disease. The Facial Mask Market is there to move along the private and public collaborations and alliances.
Sedentary lifestyle, rising geriatric population, and increasing number of people suffering from chronic diseases such as cancer, pulmonary disorders, and cardio vascular disorders have led to increase in number of surgeries. Use of facial masks during surgeries and rapid adoption of oxygen therapy is set to drive the growth of the facial mask market.
Substantial change in the burden of respiratory diseases such as chronic obstructive pulmonary diseases (COPD) and asthma has been observed, which will widen opportunities for manufacturers in the facial mask market. Medical mask market growth has been massive during the COVID-19 pandemic, as personal protection equipment (PPE) is the need of an hour.
The COVID-19 pandemic has had a positive impact on the growth of the facial mask market. Demand for N95 respiratory and surgical masks has been surging throughout the pandemic.
Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/32028
Companies covered in Facial Mask Market Report
- 3M Co
- Honeywell International Inc
- Dragerwerk AG & Co KgaA
- Fisher & Paykel Healthcare Corporation Ltd.
- Air Liquide Medical Systems
- Cardinal Health
- Koninklijke Philips NV
- CAntel Medical Corp
- Teleflex Inc.
- ResMEd
- Well Lead Medical Co Ltd
- Ambu AS
- Vincent Medical
- Flexicare Medical Ltd
- SunMed LLC
- Besmed
Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/32028
The global facial mask market is slated to expand at a CAGR of close to 5%, and cross a valuation of US$ 7 Bn by 2030-end.
Key Takeaways from Facial Mask Market Study
- Based on product, anesthesia masks is the most profitable segment, and holds around half the market value share. This is due to increasing number of surgeries that require anesthesia administration.
- In terms of usage, reusable facial masks is the leading segment, and is expected to grow 1.6X over the forecast period. Reusable masks are cost-effective and pose lower environmental burden.
- During the COVID19pandemic, many manufactures from Europe realized the potential of revenue growth and took the opportunity to launch various medical masks and respirators.
- Among the various distribution channels, hospitals and retail pharmacies lead the facial mask market. Hospitals are major consumers of facial masks due to high number of surgical procedures.
Access Full Report @ https://www.persistencemarketresearch.com/checkout/32028
“Rising prevalence of chronic diseases, especially respiratory disorders, growing burden of surgeries, and increasing awareness regarding personal and patient safety are factors expected to boost the growth of the global facial mask market. The COVID-19 pandemic has boosted market growth due to the unstoppable demand for facial masks. Due to this impact, year-on-year growth has increased to 3.9% in 2020 from 3.7% in 2019,” says a PMR analyst.
Growing Trends in Facial Mask Market
Rising awareness about effective respiratory protection and management in developed countries such as the U.S. and U.K. are seen with promotional advertisements and training programs about the usage of facial masks. Such awareness programs will help in educating people and will ultimately surge the growth of the facial mask market.
Growing preference for non-invasive ventilation masks and circuits for long-term oxygen therapy patients has also been seen in recent times. This has reduced hospital and ICU stays. Growing popularity of these masks will propel facial mask market growth.
Expansion of Manufacturing Capabilities and New Product Launches – Key Strategies by Market Players
Key players in the facial mask market are expanding their manufacturing capabilities to meet the unmet demand for facial masks. The pandemic scenario has encouraged many manufacturers to focus on in-house production, and thus expand their market presence by reaching out to a larger population. For instance, Honeywell expanded its face mask production In Europe with a new manufacturing line in the United Kingdom, in May 2020. In July 2020, Drager expanded its capability for respiratory masks and opened a production facility in the U.K.
With e-Commerce becoming a convenient sales platform for facial mask manufactures, sales will increase further in the future.
What Does the Report Cover?
Persistence Market Research offers a unique perspective and actionable insights on the facial mask market in its latest study, presenting historical demand assessment of 2015 – 2019 and projections for 2020 – 2030, based on product (medical masks [anesthesia masks, non-invasive ventilation masks, oxygen masks, and aerosol masks], respirators [single strap masks, filter dust masks, half-face masks, full-face masks, and PAPRs]) usage (reusable and disposable masks), and distribution channel (institutional sales [hospitals, ambulatory surgical centers, office-based clinics, skilled nursing facilities, diagnostic laboratories, and academic and research institutes] and retail sales [retail pharmacies, drug stores, mail over pharmacies, retail stores, and online sales]), across seven key regions.
Explore Extensive Coverage of Persistence Market Research’s Healthcare Industry
Related Reports:
Surgical Dental Loupes Camera Market:
According to the latest market report published by Persistence Market Research titled Surgical Dental Loupes and Camera Market, the global Surgical Dental Loupes and Camera Market is projected to expand at a CAGR of 9.5% during the forecast period (2016-2024).
Polycystic Ovarian Syndrome Drugs Market:
The global polycystic ovary syndrome drugs market is expected to register a CAGR of 4.6% during the forecast period 2016–2024 and is expected to expand 1.5x in terms of revenue by 2024
Lysosomal Storage Diseases Therapeutics Market:
In terms of revenue, the global lysosomal storage diseases therapeutics market is projected to register a healthy CAGR of 10.0% over the forecast period and is estimated to be valued at US$ 14.36 Bn by 2026.
About Us:
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com